Literature DB >> 11682603

The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases.

V Volmat1, M Camps, S Arkinstall, J Pouysségur, P Lenormand.   

Abstract

We previously reported that nuclear translocation is essential for p42/p44 MAPKs (ERKs) mitogenic signaling. Here we show that, during long-term stimulation, p42/p44 MAPKs become inactive while they accumulate in the nucleus. This inactivation was monitored by phospho-specific immunostaining and dephosphorylation of a nuclear p42/p44 MAPKs substrate, HIF-1 alpha. The phosphatases responsible for p42/p44 MAPKs nuclear inactivation are neo-synthesized, show tyrosine or dual specificity, and interact with p42/p44 MAPKs via a specific docking site. Likely candidates are MKP1/2 phosphatases. In addition, p42/p44 MAPKs permanently shuttle between the cytoplasm and the nucleus in quiescent as well as in serum stimulated cells. Hence, the nucleus is a critical site for mitogenic signal termination by: (1) nuclear sequestration of p42/p44 MAPKs away from MEK, their cytoplasmic activator; and (2) dephosphorylation by specific nuclear phosphatases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682603     DOI: 10.1242/jcs.114.19.3433

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  44 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

2.  Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.

Authors:  Margret Mandl; David N Slack; Stephen M Keyse
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Palladium-triggered deprotection chemistry for protein activation in living cells.

Authors:  Jie Li; Juntao Yu; Jingyi Zhao; Jie Wang; Siqi Zheng; Shixian Lin; Long Chen; Maiyun Yang; Shang Jia; Xiaoyu Zhang; Peng R Chen
Journal:  Nat Chem       Date:  2014-03-16       Impact factor: 24.427

4.  ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation.

Authors:  Diane S Lidke; Fang Huang; Janine N Post; Bernd Rieger; Julie Wilsbacher; James L Thomas; Jacques Pouysségur; Thomas M Jovin; Philippe Lenormand
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases.

Authors:  Stephen Paul Armstrong; Christopher James Caunt; Craig Alexander McArdle
Journal:  Mol Endocrinol       Date:  2009-01-29

Review 6.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects.

Authors:  Michelle C Mendoza; Fei Du; Negin Iranfar; Nan Tang; Hui Ma; William F Loomis; Richard A Firtel
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells.

Authors:  Nando Dulal Das; Kyoung Hwa Jung; Young Gyu Chai
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

9.  A quantitative image cytometry technique for time series or population analyses of signaling networks.

Authors:  Yu-ichi Ozaki; Shinsuke Uda; Takeshi H Saito; Jaehoon Chung; Hiroyuki Kubota; Shinya Kuroda
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

10.  WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Sofia D Merajver
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.